WilmerHale Counsels Braintree Laboratories in Acquisition by Sebela Pharmaceuticals

WilmerHale Counsels Braintree Laboratories in Acquisition by Sebela Pharmaceuticals

News

On May 1, 2018, Sebela Pharmaceuticals completed the acquisition of Braintree Laboratories Inc., a privately held specialty pharmaceutical company based in Braintree, Massachusetts. Braintree develops, manufactures and markets specialty pharmaceuticals in gastroenterology.

The WilmerHale deal team that counseled Braintree was led by Stuart Falber and included Keith Barnett, Steven Barrett, Robert BurkeJoseph Conahan, Julie Hogan Rodgers, Paul Jakubowski, Jeff Johnson, Rachael Kent, Amy Null, Justin Ochs, Hartmut Schneider, Laura Schneider, John Sigel, Kimberly Wethly, Brett Jackson, Michael RaineNicolette Anagnos and Ben Kelsey.

Read the press release to learn more.